Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Smith

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
BMJ Open|April 29, 2022
A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trialEleanor M Hudson, Samantha Noutch, Sarah Brown, et al.
British Journal of Haematology|May 21, 2024
Inflammatory profile of lower risk myelodysplastic syndromesJoanne Topping, Adele Taylor, Fatima Nadat, et al.
Transfusion|April 18, 2023
Comparison of platelet quality and function across apheresis collection platformsKimberly A Thomas, Amudan J Srinivasan, Colby McIntosh, et al.
BMJ Open|December 26, 2024
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, et al.
The Lancet. Haematology|February 5, 2025
Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort studyHege Kristin Gravdahl Garelius, Timothy Bagguley, Adele Taylor, et al.
Asia-Pacific Journal of Clinical Oncology|February 6, 2025
Smoking Cessation Practices in Australian Oncology Settings: A Cross-Sectional Study of Who, How, and WhenAlison Luk Young, Melissa McEnallay, Fiona Day, et al.
Leukemia|December 18, 2019
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hitFrancesco Cucco, Sharon Barrans, Chulin Sha, et al.
Asia-Pacific Journal of Clinical Oncology|February 1, 2025
A Comparison of Australian Oncology Clinicians' Smoking Cessation Care Practices for People Who Currently Smoke Versus Those Who Report Recently Stopping SmokingAlison Luk Young, Melissa McEnallay, Fiona Day, et al.
Blood Advances|January 6, 2023
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry studyIgor Stojkov, Annette Conrads-Frank, Ursula Rochau, et al.
The Lancet. Oncology|May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
BMJ Open|April 29, 2022
A Phase II trial of Higher RadiOtherapy Dose In The Eradication of early rectal cancer (APHRODITE): protocol for a multicentre, open-label randomised controlled trialEleanor M Hudson, Samantha Noutch, Sarah Brown, et al.
British Journal of Haematology|May 21, 2024
Inflammatory profile of lower risk myelodysplastic syndromesJoanne Topping, Adele Taylor, Fatima Nadat, et al.
Transfusion|April 18, 2023
Comparison of platelet quality and function across apheresis collection platformsKimberly A Thomas, Amudan J Srinivasan, Colby McIntosh, et al.
BMJ Open|December 26, 2024
Pelvis Or Involved Node Treatment: Eradicating Recurrence in Prostate Cancer (POINTER-PC) - study protocol paper for a phase III multicentre, open-label randomised controlled trialFinbar Slevin, Sophie Alexander, Sarah R Brown, et al.
The Lancet. Haematology|February 5, 2025
Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort studyHege Kristin Gravdahl Garelius, Timothy Bagguley, Adele Taylor, et al.
Asia-Pacific Journal of Clinical Oncology|February 6, 2025
Smoking Cessation Practices in Australian Oncology Settings: A Cross-Sectional Study of Who, How, and WhenAlison Luk Young, Melissa McEnallay, Fiona Day, et al.
Leukemia|December 18, 2019
Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hitFrancesco Cucco, Sharon Barrans, Chulin Sha, et al.
Asia-Pacific Journal of Clinical Oncology|February 1, 2025
A Comparison of Australian Oncology Clinicians' Smoking Cessation Care Practices for People Who Currently Smoke Versus Those Who Report Recently Stopping SmokingAlison Luk Young, Melissa McEnallay, Fiona Day, et al.
Blood Advances|January 6, 2023
Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS Registry studyIgor Stojkov, Annette Conrads-Frank, Ursula Rochau, et al.
The Lancet. Oncology|May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster, et al.
Pageof 13